Skin, as the largest organ, has long been subject of excellent and pioneering studies on stem cells and their role in tissue regulation and tumor formation. In particular, intensive research on mouse skin, and here especially the hair follicle, has largely extended our knowledge. Surprisingly, human skin, although the most easily accessible tissue in man, is far less conceived with regard to its stem cells and their specific environment (the niche). In consequence, these features are as yet only insufficiently defined and it still has to be elucidated how insights in cutaneous stem cell biology gained in mice can be extrapolated to humans. In the last few years, human model systems such as humanized mice or in vitro organotypic cultures that support maintenance or reconstruction of human skin and long-term epidermal regeneration have been developed. These models allow lineage tracing experiments and can be modified by adopting genetically manipulated cell types. Accordingly, they represent proper tools for human stem cell research and will clearly help to improve our still incomplete understanding. Like normal skin, the non-melanoma skin cancers and their respective tumors have gained considerable interest in basic as well as in clinical research. Being the most frequent human tumors globally, basal cell carcinomas and cutaneous squamous cell carcinomas (SCCs) continue to increase in incidence and specifically SCCs predominate in immunosuppressed transplant recipients. This review intends to compile the present knowledge on keratinocyte stem cells and their niches in normal skin and skin carcinomas with a special focus on the human situation. In particular, the role of the microenvironment, the niche, is emphasized, promoting our view of the decisive importance of the niche as a key regulatory element for controlling position, fate and regenerative potential of the stem cell population both in healthy skin and in carcinomas.
Introduction
Grand expectations have been imposed in adult (or somatic) stem cells that rapidly moved them into the focus of research. They represent a long-lived population of cells that have the capacity to selfrenew and to regenerate tissue(s) for the entire life time of the body, both in tissue homeostasis and wound repair. These remarkable characteristics make them a specific and most essential class of cells in the living organism.
Although defining the true identity of human stem cells as well as their requirements for functionality throughout life of a human body has remained difficult, progress in mouse genetics have provided appropriate tools for their characterization and validation. Accordingly, functional and lineage tracing assays have allowed for the identification of well-defined populations of stem cells in several organs, including skin. Skin as the cutaneous outer barrier is protecting the body against water loss, infiltration of deleterious and infectious agents and photo damage. Anatomically, it is a two-compartment tissue comprising a stratified squamous epithelium, the epidermis and a matrix-rich connective tissue, the dermis. As the largest and most easily accessible organ, skin has long been a subject of stem cell research, and stem cell populations have been identified at specific sites within the epidermis. These separate sites, which are in the epidermal hair follicle (HF), in the stretches interconnecting hair follicles, the interfollicular epidermis (IFE) and in the sebaceous gland (SG), strongly differ in their tissue-dependent organization, functionality and environmental quality (the niche).
The different sites of epidermal stem cells
The murine HF Most of our present knowledge on epidermal stem cell comes from research on murine HFs. This epidermal appendage dominates murine skin and undergoes regeneration every 4 weeks. For a long time, a specific site, the bulge region of the HF, was thought to be the only area harboring stem cells (for review, see ref. 1). However, even within that specific region, heterogeneity has been observed as stem cell populations exhibiting different locations (basal versus suprabasal) and different characteristics [slowly cycling (quiescent) versus rapidly cycling] (2) (Figure 1 ). More recently, work on orphan G-coupled receptors (Lgr5 and Lgr6) by the Clevers laboratory included additional stem cell populations, thereby adding to the diversity of stem cell populations presently being discussed for murine HF development and maintenance (3) . Moreover, a stem cell population has been described in the murine SG ( Figure 1 ) and further in the upper infundibulum of the HF, which are believed to contribute to the maintenance of the murine IFE (4) . It was recently suggested that during the hair cycle of mouse HFs, the bulge stem cell population expands, before a fraction exits the bulge, and subsequently populates the hair germ where it establishes as a progenitor population of Lgr5þ stem cells (for review, see ref. 5) . A similar situation might exist for the Lgr6þ, MTS24þ and Lrig1þ stem cells populations that occupy partially overlapping stem cell niches located between the upper bulge edge and the infundibulum (6) . Further progress in characterizing these populations and their fate may certainly dissipate their overwhelming diversity.
The human HF
In contrast to the murine HF, the composition of stem cells in the human HF is still largely elusive. Actually, very little of the knowledge on murine HFs could yet be applied to human HFs. For example, Keratin 15 which is limited to the murine HF bulge region and used to isolate HF stem cells (7) did not emerge as a marker with sufficient specificity for human bulge cells (8) and CD34 did not prove applicable at all, i.e. CD34 positivity was restricted to the hematopoietic cells in humans. Instead, CD200 was proposed as a corresponding human bulge stem cell marker (9) . Indeed, transcriptional profiling of human bulge cells has revealed similarities but also important distinctions between mouse and human bulge cells ((10) and references therein). It is noteworthy that mice display a broad diversity of hair types, whereas humans are restricted to terminal hairs, found on the scalp, and vellus hairs in facial and trunk skin. Moreover, the morphology of human versus murine HFs differs. In humans, the most prominent HF stem cell site, the bulge, is extended in length and less prominent as it is largely integrated into the outermost layer of the HF structure, the outer root sheath, which is a multi-layered and homogeneously organized epithelial tube, while being a single layer of cells in the murine HF bulge. Finally, large differences exist in the cycling time. Whereas murine HFs regenerate every 4 weeks, human HFs are rather stationary with a growth phase of a single hair up to 8 years. As in structure and dynamics, human and mouse HFs are remarkably different, this could implicate that man differs from mouse also in composition and topology of HF stem cell populations. However, not until techniques for genetic tagging and lineage tracing are applicable to experimental models of human HFs, one can expect to clarify whether similar conditions of stem cell diversity as in mouse HFs also exists in humans.
The murine IFE
In contrast to the HF, much less is known about stem cells in the IFE. Although linage tracing experiments have clearly demonstrated that tissue homeostasis in mouse epidermis is maintained by an independent stem cell population (11, 12) , their origin and localization is still a matter of debate. Upon wounding, HF stem cells are thought to contribute to the repopulation of the IFE. Furthermore, in response to a proliferative stimulus of the IFE, a selective expansion of the stem cell population of the junctional zone (Lrig1þ cells) into the IFE has been observed (4) . For the Lgr6þ stem cells from the upper bulge region in mice, it is suggested that they contribute to epidermal progenitor cells even in the absence of wounding (6) . In this context, it may be worth to note that in mouse skin, the HF density is considerably higher with only short distances between HFs as compared with human skin and that specific contraction of wounded murine skin leads to further accumulation of HFs at the wound margin. Thus, plenty of HF stem cells are at disposal to fuel re-epithelialization of the skin defect.
The human IFE This situation may be different for human skin where the IFE predominates, and actually in some regions, HFs are completely missing (e.g. foreskin). Instead, the human epidermis is characterized by increased stratification and differentiation into distinct cell layers. At sites of higher force (e.g. palmoplantar skin), the epidermis is tightly interconnected with the dermis through so-called rete ridges, which have been suggested as preferential stem cell sites in the IFE. On one hand, the tip of the rete ridge where the dermis is closest to the outer surface was proposed to contain a stem cell population distinguished by high expression of b1 integrin (b1 high ), melanoma chondroitin sulfate proteoglycan þ and the epidermal growth factor receptor (EGFR) antagonist Lrig1þ (4, 13, 14) . On the other hand, Kaur et al. demonstrated that a6 integrin high and CD71 low cells from the base of the rete ridges, furthest away from the skin surface, gave rise to long-lived clones in culture and exhibited an extensive growth potential when transplanted (15) . Some clarification of this discrepancy came from elegant studies of Ghazizadeh and Taichman (16) . By transplanting human foreskin epidermis onto nude mice and infecting the basal cells with a lentivirus encoding a fluorescent marker protein, they have mapped labeled columns of cells over a 28-week period. These studies revealed that stem cells are dispersed along the basal compartment (16) .
To obtain a versatile experimental tool for investigating IFE stem cells, our laboratory established an organotypic culture (OTC) (also called 'air-lift cultures') model allowing human epidermis to regenerate for several months (.12 weeks) (17) . Pulse-chase experiments with nucleotide analogous recapitulated the original finding by Bickenbach (18) , confirming that a small portion of slowly cycling labelretaining cells (LRCs) also established in human IFE (19) . Since the þ stem cell population characterized by their diverse expression of a6-integrin (a6) and Lgr5. A Lgr6 þ actively cycling stem cell population is present directly above the CD34 þ bulge, whereas CD34
� cells reside at the isthmus below the SG. The SG owns a dedicated stem cell population marked by CD34 (20) , where an inducible green fluorescent protein-tagged histone H2B is expressed and upon switching off its expression serves as a reporter for the slowly cycling stem cells in the murine HF. This approach has now been adapted for labeling of human keratinocytes (21) , thus opening access to the isolation and further characterization of LRCs which at present represent the most reliably identified stem cell population of human IFE.
Components contributing to the epidermal stem cells niche
The potential to exert its proper stem cell function is a combination of intrinsic characteristics of the stem cell and extrinsic inputs by its local microenvironment, referred to as the stem cell niche (22, 23) . The term 'niche' is borrowed from ecology and defines where an organism lives, what it does and how it interacts with its environment (24) . Stem cell niches are complex structural units that facilitate the interaction between the stem cell and its surrounding cells in a spatially and temporally defined manner in order to maintain tissue homeostasis (25) . Moreover, the niche includes extracellular components as well as diffusible factors that are integrated to provide the proper regulation of the stem cell (26, 27) .
It has been proposed that the different epidermal stem cell populations of the murine HF, leading to the term 'stem cell zoo' (28), may, despite their diversity, be functionally equivalent and interconvertible. It was further suggested that their differentiation potential may be largely, if not solely, determined by their local microenvironment (29) . Accordingly, human epidermal stem cells cannot be maintained long term in culture and rapidly lose their 'stemness'. Even a threedimensional configuration in OTCs does not preserve their functional competence when fibroblast support is missing, clearly underlining the significance of fibroblasts in establishing a functional stem cell niche.
The HF bulge, as a distinct location, is an established and thoroughly studied model for a specific niche. However, the identification of additional stem cell clusters along the HF with similar functional properties but different expression profiles (Figure 1 ) supported the important and instructive role of their microenvironmental niches as well. In the IFE, on the other hand, a specific niche will be difficult to define in morphological terms. Nevertheless, patterns or gradients in structural elements and/or positive and negative signals must exist in order to generate niches that guarantee unlimited maintenance and functionality of the stem cell population.
The basement membrane
One major intrinsic niche feature is the contact of the epidermis with the contiguous basement membrane (BM). The BM is a complex network of extracellular matrix molecules, comprising several laminins, type IV collagen, nidogen and perlecan and providing a stabilizing but nevertheless also dynamic interface between the epidermis and the underlying dermis. In loss-of-function experiments using nidogen-deficient fibroblasts in human skin OTCs, the formation of a structured BM was abolished, and in response the keratinocytes showed altered adhesive properties and organization (30) ; thus demonstrating that an accurate assembly of all components to a regular BM structure is crucial for epidermal histogenesis (30) . In skin OTCs coated with individual matrix proteins, type IV collagen allowed for the formation of a neo-epidermis with improved tissue architecture in conjunction with a fully matured BM (31) . Remarkably, also coating with laminin 10/11 supported the formation of a stratified human epidermis even from early-differentiated cells (32) . Furthermore, as an important cofactor, stabilizer and storage of growth factor molecules, the BM is essential in several growth factor signaling pathways. Therefore, it represents not only a structural element but also efficiently fulfills regulatory functions (33, 34) .
Integrins
Anchorage and interaction of epidermal keratinocytes with the BM is to a large extent mediated by integrins whose expression patterns and specific features are perfectly described elsewhere (35) . They serve not only as adhesive proteins but also in sensing the quality of the environment. When epidermal morphogenesis proceeds, integrin patterns and BM organization achieve a normal state and this is tightly correlated with tissue homeostasis (36) . High expression of b1-and a6-integrins was reported as a marker of human epidermal stem cells and has been further associated with maintaining epidermal stem cell function (13, (37) (38) (39) . Loss or alteration of integrin expression determines departure from the stem cell niche through differentiation or apoptosis (40) . Accordingly, in collagen-based OTCs, epidermal atrophy was preceded by matrix metalloprotease (MMP)-induced destruction of BM and dermal matrix components and accompanied by disorganization of integrin subunits. Consequently, suppressing degradation by MMP inhibitors could significantly extend the regeneration phase of the human keratinocytes (19) .
The extracellular matrix
In the underlying connective tissue, the dermis, fibroblasts are the major cell population active in synthesis and regulation of extracellular matrix (ECM). The major protein components of the dermal matrix are collagen fibers, elastic fibers and non-fibrous molecules, including glycoproteins, proteoglycans and glycosaminoglycans. These constituents undergo continuous turnover and remodeling in skin homeostasis, pathological situations and in response to external stimuli. The composition of the ECM is known to be important in a variety of fundamental cellular events such as proliferation, migration, differentiation and morphogenesis as excellently compiled by Lu et al. (41) . This justifies the conclusion that the matrix is also a decisive factor for the establishment and regulation of epidermal stem cells.
OTCs as a functional model for human epidermal stem cells
Excellent experimental tools for respective studies are OTCs as threedimensional in vitro models of human skin (reviewed in refs 42,43). Initially, human keratinocytes established a well stratified and differentiated epidermis, however, epidermal regeneration generally ceased within 3-4 weeks. From this it was suggested that explants and OTCs merely promote differentiation but not retention of stem cells (44) . As could be shown later, inhibition of matrix and BM degradation doubled the OTC-life span from 4 to 8 weeks (19) . This interpretation therefore turned out to be invalid as the crucial parameter is obviously not the stem cell but the preserved quality of its stem cell niche. Accordingly, when modifying the dermal equivalent in a way that allowed for the formation of an authentic dermis-like matrix, epidermal long-term regeneration was achieved (17, 45) . These studies also confirmed the major impact of keratinocytes on ECM assembly and maturation in the dermis and clearly underlined the relevance of mutual epithelial-mesenchymal interaction for establishing a proper stem cell niche (46) (47) (48) (49) .
That said, it is interesting to note that upon grafting of sheets of autologous cultured IFE-keratinocytes onto deep dermis of burned victims, a fully stratified epidermis developed rapidly. However, the normal dermal composition of a papillary and reticular dermis with fine collagen fibers in the subepidermal region and thicker fibers only Epidermal stem cell niche regenerated in the long-run (reviewed in ref. 50) . Together with the data from the OTCs, this may suggests that upon proper cross talk between keratinocytes and fibroblasts, the stem cell niche can develop despite the fact that the dermis is not yet fully structured. However, HF and SG did not develop in these transplanted areas. Thus, instructive cues for de novo HF development is absent in deep dermis and do not seem to re-establish during dermal reconstruction in the adult.
In addition to the extracellular milieu, stem cells interact directly with adjacent stromal cells through cell surface receptors, gap junctions and soluble factors (23) . Those cells and the signals emitted by them are also to be considered as stem cell niche constituents. In the epidermis, cells contributing to the niche are fibroblasts, endothelial cells and inflammatory cells but presumably also neighboring keratinocytes and melanocytes, Merkel cells and Langerhans cells. Thus, epidermal stem cells reside in fine-tuned microenvironments that are controlled by constant cell-cell and cell-matrix interactions.
Communication via signaling pathways
In the niche, both stem cell quiescence and activation have to be precisely regulated. Accordingly, different signaling pathways seem to actively be involved in the regulation and maintenance at the different stem cell sites.
Wnt pathway
As reviewed elsewhere (51), one prominent branch of this complex signaling network in the HF is the canonical Wnt/b-catenin pathway. Wnt activation induces expression of Tcf3 (T-cell factor 3) in murine HF stem cells, which is crucial for maintenance of a multipotent cell phenotype (52) (53) (54) (55) . Blocking Tcf3#s actions resulted in a stem cell differentiation along epidermal and sebocyte lineages (53, (56) (57) (58) . Thus, Wnt-mediated gene activation apparently determines the commitment of murine HF bulge stem cells to either maintain their quiescent state or to enter the hair differentiation lineage (59, 60) . In addition, the canonical Wnt pathway serves as a key regulator of epidermal lineage selection (for review see ref. 61 ).
Shh pathway
A second important regulator explored in murine HFs is the sonic hedgehog (Shh) pathway (62) (63) (64) . Interacting gradients of activators and inhibitors create an inductive field in the embryonal epithelium and the underlying mesenchyme in order to induce placode formation as the first step of HF development (65) . Once a placode has formed, signals from the epithelium instruct the underlying dermal cells to form the follicular dermal papilla (66) . In this context, Shh is one of the early genes activated in order to organize the dermal cells into the dermal papilla (67) . Eventually, a feedback of morphogenic signals to the ectoderm induces HF formation (65) . These mechanisms are also postnatally active during HF cycling demonstrating that the dermal papilla continues to play a pivotal role in inducing the bulge stem cells to initiate HF morphogenesis (68, 69) .
Notch signaling
In the IFE, Notch signaling is known to participate in cell fate decisions and regulation of proliferation and differentiation (70) (71) (72) . Expression of the Notch ligand Delta1 is confined to the basal layer of human epidermis, with highest expression in regions presumably harboring stem cells what indicates a role for Notch/Delta signaling in epidermal stem cell maintenance (73) . Further studies with murine keratinocytes demonstrated that Notch signaling involves cross talk with p63, a critical regulator of epithelial development and morphogenesis that also controls epithelial-mesenchymal cross talk (74) (75) (76) (77) . Active Notch signaling directs keratinocyte cell cycle arrest and differentiation what is counteracted by p63. Furthermore, Notch signaling suppresses p63 expression, thereby constituting a regulatory feedback loop. Apparently, epidermal differentiation and maintenance of IFE is determined by a fine-tuned balance between intracellular levels of Notch and p63 (67, 72) . Clearly, notch signaling is not only operative in IFE as both gain and loss of Notch signaling demonstrated hair loss due to hair cycle disturbances as well as SG disorders in murine models (78) (79) (80) (81) . However, it might exert distinct effects in the IFE compared with the HF (66, 72) .
EGFR signaling
Another crucial regulator of homeostasis in the IFE and already explored more extensively also in human epidermal cells is the EGFR with its multiple mediators such as amphiregulin, epiregulin, heparin binding-epidermal growth factor and transforming growth factor (TGF)-a, all acting in an autocrine and paracrine manner (82) . Several major EGFR-activated pathways are described, such as MAPK, PI3K/ AKT, JAK/STAT and PKC cascades (83) . The defects in epithelial tissues of mice lacking EGFR suggest that EGFR signaling is crucial for maintaining normal epidermal development (84) (85) (86) (87) . Interestingly, EGFR downregulation during embryonic hair placode development appeared to be decisive for specification of follicular rather than epidermal cell fate (88) . Furthermore, antagonizing interaction of EGFR and Notch family members in the differentiating epidermis resulted in their mutual downregulation (89,90) strongly argues for an essential functional interdependence.
Additional paracrine regulatory pathways Paracrine interactions are of central importance in epidermal histogenesis and regeneration and a double paracrine signaling loop has been discovered for an epidermal-dermal cross talk in human skin cells (91, 92) . Keratinoytes actively elicit the production of required growth factors by expressing interleukin-1a and interleukin-1b, which, in turn, induce expression of KGF/FGF7 and GM-CSF in dermal fibroblasts through activator protein 1 activation (91) (92) (93) . Mouse studies further demonstrated that activator protein 1-dependent expression of pleiotrophin and stromal cell-derived factor 1 regulate keratinocyte proliferation and differentiation (94) . However, this is only part of an extensive regulatory network controlling epidermal tissue morphogenesis and homeostasis. Another key player therein is the TGFb with its dual function of keratinocyte growth inhibition and fibroblast activation (for review, see ref. 95) . Its importance in epithelial biology is substantiated by studies compromising TGFb signaling in murine epithelia. Although tissue homeostasis was apparently maintained in these mice by balancing hyperproliferation with elevated apoptosis, spontaneous squamous cell carcinomas (SCCs) developed with age (96) . Decisive role of TGFb in controlling human epidermal integrity was similarly demonstrated for the human HaCaT keratinocytes. Abrogated TGFb signaling caused altered tissue homeostasis with hyperplastic growth due to overproduction of growth factors by the fibroblasts (97) . Surprisingly, also reprogramming toward alternative epithelial differentiation was observed. However, the proliferative quiescence of the LRCs remained unchanged upon abrogation of TGFb signaling indicating that stem cell quiescence in the IFE is not regulated by TGFb (J.Kollar, H.-J.Stark, P.Boukamp, unpublished results).
To summarize, multiple context-dependent mechanisms and signaling pathway interactions are relevant for epithelial development and stem cell fate determination. But still, the relevant control mechanisms for the respective stem cell populations and site-specific regulatory pathways are far from being understood and still require substantial investigation.
Non-melanoma skin cancer
Similar as normal epidermal regeneration is maintained by somatic stem cells, also skin cancer development and progression is dependent on specific tumor-initiating cells and a specific microenvironment or niche. That said, skin cancer is a complex process believed to arise from single cells where genetic alteration causes failure of tissue growth regulation, and long-lived stem cells in the skin indeed have the opportunity to accumulate oncogenic mutations over years or decades.
However, the connection between the epidermal stem cell, its niche and skin cancer development is still under intense investigation.
Non-melanoma skin cancer is the most common neoplasm in humans with the basal cell carcinoma (BCC) being the most frequent one. Although generally non-metastatic, BCC can be highly destructive. The second most frequent skin cancer is the SCC, which differs from BCC in starting from precancerous stages with specific clinical, histological and molecular features and having the potential for tumor progression including metastasis (98) . In immunosuppressed organ transplant recipients, SCCs occur 65-250 times more frequently than in the general population, are more aggressive and metastasize in up to 10% of the patients. The development and progression of both tumor types is linked to ultraviolet (UV)-radiation. While intense early-age UV exposure is supposed to specifically contribute to BCC development, chronic UV damage is thought to be responsible for SCC development and progression (reviewed in ref. 99 ).
Stem cells: the cell of origin of human skin carcinomas
Although not fully identified, the cell of origin of both BCCs and SCCs is likely to be a stem cell. The most rational argument for it is that the epidermis is a continuously renewing tissue where all keratinocytes that leave the stem cell compartment undergo a welldefined process of differentiation which is terminated in the formation of dead horn squames. Accordingly, if damage manifests in any other cell than a stem cell, it is likely to be eliminated due to the differentiation process. However, if a rarely dividing epidermal stem cell is affected, its long-lived nature can permit the accumulation of multiple genetic hits that finally override cell cycle control and allow neoplastic growth. As an alternative way, non-stem cells may persist and allow for tumor initiation if their genetic alterations interfere with differentiation, thus preventing their elimination.
This hypothesis is indeed reflected by the distribution found in human BCCs. It is long known that in skin carcinoma development, mutation-dependent inactivation of p53 is an early event and that a high number of these mutations carry an UV-indicative signature (for review see ref. 100). Individual cells, i.e. potential stem cells, with intense nuclear accumulation of immunoreactive p53, suggestive for mutated p53, can be detected in chronically sun-exposed human skin, along with clones of morphologically normal keratinocytes (98) . As mutated p53 abrogates normal p53 function, further resistance to UV-induced apoptosis would be implicated (101) . Furthermore, a remarkable heterogeneity with respect to p53 mutations in human BCCs has been reported. By investigating clonality in parts of microdissected tumors, the cellular composition was shown to be dominated by a clone prone to genetic progression. However, also multiple genetic events were demonstrated as subclones within the same tumor area carried second and even third p53 mutations (102) .
Another line of evidence comes from studies on mouse SCC development where the concept that rather the slowly dividing LRCs and not the rapidly proliferating transit amplifying cells are capable to expand during skin tumor promotion is long established (reviewed in ref. 103) . Already in the 1980s, it was shown that in mice with [ 3 H] thymidine-labeled epidermal LRCs, these LRCs scarcely underwent mitosis and remained in the basal layer upon 12-O-tetradecanoylphorbol 13-acetate treatment, whereas the proliferating cells dislocated rapidly from the basal layer undergoing terminal differentiation (104) . Furthermore, LRCs of both HF and IFE retained carcinogen-DNA adducts (105) , and even after ablation of cycling cells in the epidermis with a chemotherapeutic drug prior to 7,12-dimethylbenz[a]anthracene treatment, the rate of carcinoma formation was unchanged, indicating that tumor initiation occurred in quiescent (stem cells) rather than rapidly proliferating (transit amplifying) cells (106) .
HF or IFE: the site of origin of BCC and SCC
Several lines of evidence suggest that human BCCs may arise from the HF. BCCs only occur in hair-growing squamous epithelium (98) , and both the cytokeratin profile and the expression of the nuclear transcription factor Sox9 in BCCs were almost identical to the expression in the HF outer root sheath while being distinct from that in IFE (107, 108) . Furthermore, BCC development is linked to mutationdriven aberrant activation of the Shh pathway (reviewed in ref. 109) , with the Shh receptor Ptch1 being the most frequently mutated gene in human BCCs (reviewed in ref. 110 ). As discussed above, the Shh pathway is essential for the regulation of HF cycling but not for IFE homeostasis (111) . Additionally, the HF stem cell marker Lgr5, which is expressed downstream of the Shh pathway and shown to promote cell proliferation and tumor formation, had elevated expression levels in 95% of human BCCs (112) .
However, recent studies with Ptch1 þ/� mice question the HF as the only site of origin. While cell fate tracking in X-ray induced BCCs identified the keratin 15-expressing HF bulge stem cells as the exclusive cell of origin (113) , conditional loss of p53 in the epidermis of these Ptch1 þ/� mice resulted in BCCs evolving from the IFE (113) . Similarly, by specific activation of Shh signaling in different cellular compartments of mouse skin, not HF bulge stem cells but long-term resident progenitor cells of the IFE and upper infundibulum gave rise to BCCs (114) . Indeed, by selectively inducing the major mediator of Shh signaling GLI2 in stem cells of resting and growing hair follicles or in the basal epidermis in mice, Grachtchouk et al. (115) could show that the phenotype of these skin tumors (BCCs) was determined by the cell of origin (HF versus IFE), by the tissue context (quiescent versus growing hair follicles) and by the level of oncogenic signaling.
For human SCCs, malignant transformation is discussed to be initiated in an IFE stem cell, thereby giving rise to a tumor phenotype characterized by squamous differentiation. As a causal carcinogen, UV radiation is supposed to induce the initial hit and to contribute to subsequent accumulative damage. Accordingly, SCC mostly occur at sun-exposed sites, are virtually absent in deeply pigmented skin and exhibit an UVB-indicative p53 mutation spectrum (99) . As UVB radiation is thought to only reach the basal layer, this limited penetration depth strongly argues for the IFE as the preferred target of UVB radiation in human skin. In line with that, UVB-indicative p53 mutations are often found in areas of morphologically normal human epidermis, the potential precursor lesions actinic keratoses, and in SCCs. Microdissection studies of human SCCs and adjacent lesions revealed that both carried identical mutations, indicating that invasive skin cancer and its pre-stages derived from the same original neoplastic clone. However, also morphologically normal epidermis with sharply demarcated areas of mutated p53 was found that did not display the same p53 mutation as the adjacent tumor, showing that the mutations were separate events and precluding the general existence of a common cellular SCC precursor (116) .
While previous mouse models using UV radiation to induce and enhance growth in SCCs supported the origin of SCCs from IFE (reviewed in ref. 98 ), Faurschou et al. reported that also UV-irradiated mice which had their IFE removed developed SCCs. Hence, SCCs in these mice had to originate from the HF, presumably from bulge stem cells, indicating that UV radiation was able to penetrate sufficiently to cause irreversible DNA damage in cells located in the HF (117) . Likewise, the two-stage skin carcinogenesis protocol suggested for an HF origin of SCCs. This mouse tumor model, originally described as Berenblum experiment (118), is based on 7,12-dimethylbenz[a]anthracene-dependent mutational activation of the H-ras oncogene, followed by continuous treatment with the tumor promoter 12-O-tetradecanoylphorbol 13-acetate causing hyperplasia and genomic instability. With this 7,12-dimethylbenz[a]anthracene/ 12-O-tetradecanoylphorbol 13-acetate protocol Morris et al. (119) demonstrated that the targets of tumor initiation were stem cells located in the HF and, to a lesser degree, in the IFE. By removing the IFE of those mice, papillomas and carcinomas developed; however, the frequency of papillomas was only 50% of that in unabraded mice. Carcinoma progression, on the other hand, was not significantly different (119) . By choosing a genetic approach, White et al. (120) targeted K-ras mutation and p53 gene deletion specifically to the bulge HF thereby triggering SCC formation in this stem cell-harboring area. In contrast, specifically targeted transit amplifying cells did not induce Epidermal stem cell niche the generation of even benign tumors (120) . If this would argue for ras mutations providing a unique growth advantage in HF stem cells, it will be of interest to further unravel whether also the subfraction of ras mutation-positive human SCCs are HF-derived.
Cancer stem cells in human BCC and SCC
It is now widely believed that most tumors contain a subpopulation of malignant cells with stem cell properties, an idea already proposed by Virchow in 1855. Because of their ability to self-renew and to generate differentiated progenies, these were termed CSC (reviewed in refs 121-124). Actually, skin SCCs are excellent examples for the perception that a tumor is an organ per se (for review, see ref. 125) in which a stem cell hierarchy is maintained. The majority of cutaneous SCCs retain a structural organization similar to their tissue of origin with proliferating (basal) cells, closely attached to a BM which in turn is separating tumor islands from stromal strands. Differentiation proceeds toward the interior of the tumor mass, terminating in a variable degree of cornification. Even poorly differentiated SCCs still exhibit a certain degree of structural order. Because of this intrinsic bias to differentiate, it is not too surprising that not all human tumor cells are able to re-establish a tumor in xenotransplants. Labeling of these tumors for quiescent, potential stem cells identifies a small fraction of LRCs persisting in human xenotransplants (our unpublished results). Whether these cells are comparable with the recently described subpopulation of CD133þ cells in human SCCs that were shown to be unique in their ability to establish new tumors upon retransplantation (126) remains to be seen. For mouse SCCs, Schober and Fuchs provided compelling evidence for multiple CSC pools along the tumor-stroma interface (CD34 high and CD34 low cells) which all depended on high integrin expression. Although identified as distinct CSC pools with rapidly proliferating CD34 low presumptive IFE-and slow-cycling CD34 high potential HF stem cells, the authors proposed that these CSC pools were actually interconvertible (127) . Unfortunately, CD34 is not applicable as marker in human skin and as also other reliable markers are still missing, the challenge still remains to comprehend such CSC diversity for human cutaneous SCCs. It is also important to note that the human SCCs develop over decades in the body with sufficient time to establish and accumulate genetic diversity with intratumoral subpopulations having different tumorigenic potential. Unfortunately, this time aspect cannot be addressed neither in genetically or chemically induced mouse tumors nor xenotranspants of human skin cancer cell lines on mice.
Taken together, particularly due to upcoming and increasing evidences from mouse studies a novel view emerges that, in contrast to our previous understanding, BCCs may not derive from HFs but may originate at least in part from the IFE. Conversely, SCCs-long believed to originate from the IFE-can in more and more details be attributed to HFs. Whether this directly transfers to the human situation remains to be seen. In addition, the specific selection of the genetic mouse models and in particular the species-specific differences in tissue organization of mouse versus man may be limiting for a unifying conclusion. Even though the question of the identity of CSCs in human skin carcinomas remains elusive, it is plausible to anticipate that the origin of both BCCs and SCCs, involves a stem cell or precursor cell and that at least SCCs are still able to establish a stem cell-like hierarchical organization.
The skin cancer microenvironment
As in the normal epidermis, where epidermal stem cell organization and regeneration is dependent on a proper niche, also skin carcinomas depend on a highly instructive and functional microenvironment. This is in compliance with a recently emerging view that solid tumors are no more considered simple clones of cancer cells but are abnormal organs that interface with the entire organism and the crucial role played by the tumor microenvironment, the stromal niche, is commonly accepted as excellently reviewed by Egeblad et al. (125) .
The specific environment of BCCs
The specificity of the stromal environment has long been recognized for human BCCs, as they are unable to grow in a tissue environment other than their specific stroma. Already in the early 1960s, Scott and Reinertson reported that BCCs maintained their characteristic morphological features only when transplanted together with their original stroma (128) . Also more recent attempts to grow human BCCs as mouse xenografts are still hampered by the low percentage of tumor uptake and slow growth rates (reviewed in ref. 113 ). Accordingly, human BCCs cannot be maintained in conventional cell culture. Even upon co-cultivation with their specific tumor-associated fibroblasts, they rapidly lose their growth potential and become committed to terminal differentiation (own observations). This may suggest that the fibroblasts and their allocated factors are insufficient to support the undifferentiated and proliferative state of the BCCs. Instead, they require a specifically structured three-dimensional microenvironment with its distinct matrix and cellular composition (108) .
From the several BCC subtypes, the most frequent one conferring low risk is the nodular BCC. Histopathology demonstrated a characteristic separation of the tumor from the surrounding stroma by optically empty appearing clefts. While long discussed as an artefact of histological processing, these clefts are now thought to be caused by accumulation of amorphous mucin-like material (129) . On the other hand, the 'high-risk' morphoeic subtype (also named sclerosing or fibrosing), which occurs mostly on the face (head and neck) exhibits an infiltrative growth pattern and is composed of small islands and strands of neoplastic cells embedded in a dense fibrous stroma enriched with hepatocyte growth factor-secreting myofibroblast (130) . As the interaction of this particular kind of stroma is implicated in more aggressive growth, this example impressively reveals the decisive role of stromal quality in controlling the tumor phenotype via modulated niche conditions in the microenvironment.
As discussed above, mutational activation of the Shh pathway is one of the causal factors involved in the development of BCCs. It is intriguing that also in medulloblastomas, the most common malignant pediatric brain tumors, aberrant Shh signaling is implicated in tumorigenesis and that their stroma structurally resemble that of BCCs (131) . Thus, what emerges as a common feature of tumor formation induced by dysregulated Shh signaling is the development of a specific type of stroma obviously harboring tumor supportive niche properties. Theunissen and de Sauvage (132) reviewed different mouse models and suggested that Shh signaling in stromal cells probably results in the expression of soluble factors and ECM components that act upon the tumor epithelium or other cell types ultimately promoting tumor growth. Alternatively, other than Shh-activators themselves, downstream target genes of the Shh pathway could affect the specific alteration of the stroma. As possible candidate genes, platelet-derived growth factor (PDGF) A and B and the PDGF-receptors a and b were described. Similar as induction/growth of skin structures being dependent on PDGF alpha-receptor expression in the mesenchyme, a and b receptors were found in the specific stroma components of human BCCs, whereas the A and B chains were mainly found in the tumor cells (133) . Additionally, PDGF receptor-like protein was identified (134) . In hypertrophic breast reduction scars, augmented epidermal PDGF production led to increased formation of dermal matrix (135) supporting the notion of a close connection between wounds and cancer and underlining the pivotal role of the ECM.
Undisputable is also the importance of stromal fibroblasts as key regulators of the specific stromal microenvironment. One sign of fibroblast activation is the acquisition of a myofibroblast phenotype featuring the expression of a-smooth muscle actin. An increased density of myofibroblasts could thus be a key feature of human BCCs. Accordingly, it was demonstrated that aggressive morphoeic BCCs had many myofibroblasts in their fibrous rim, whereas the non-aggressive nodular BCCs with a mucous periphery had only few myofibroblasts but expressed a-smooth muscle actin in the tumor cells (136) . As a potential mechanism of transdifferentiation from stromal fibroblast to myofibroblasts, Marsh et al., proposed an
avb6-dependent activation of TGF-b1. They further discussed that the myofibroblasts in turn promote BCC invasion through upregulated secretion of hepatocyte growth factor/scatter factor as myofibroblasts express hepatocyte growth factor/scatter factor and the morphoeic BCCs are strongly c-Met (receptor)-positive (130) . BCC-derived fibroblasts also differ from normal stromal fibroblasts in morphology, control of contact inhibition, fibroblast surface antigens as well as progressive aneuploidy when kept in cell culture for longer periods (137) . In addition, they express a number of proteins previously implicated in so-called carcinoma-associated fibroblasts in various other tumor types (134) . Thus, the fibroblasts present in the microenvironment of the different BCC types seem to exhibit distinct phenotypes and thus the physiology of these stromal cells is of vital importance for the quality of the stromal microenvironment in controlling aggressive versus non-aggressive growth of BCCs.
A very important though still poorly understood aspect of the tumor niche is the organization of its ECM. As stated above, BCCs are characterized by a rim of fibrous matrix. So far it was shown that matrix components such as fibronectin were overexpressed while vitronectin was reduced in peritumoral stroma (138) . On the other hand, nodular BCCs are enriched in hyaluronic acid when compared with normal adjacent skin (139) . As the concentration and organization of these macromolecules may well be of regulatory consequence for the formation of gradients and thus for the formation of regional niche-dependent changes, further elucidation may be expected from new high resolution and in particular non-invasive microscopy techniques. As cells and ECM intrinsically contain a variety of fluorescent molecules, they can be imaged in a time-resolved manner without any exogenous probe. By measuring, e.g. the two photon emission spectra of different endogenous fluorescent species by multispectral (MTPE) tissue imaging, it was already possible to discriminating healthy skin from BCC (140) . It will, therefore, only be a matter of time before these techniques enable a more precise analysis of the matrix texture responsible for the respective tumor phenotype.
This tumor microenvironment is not static but constantly modulated (degraded and rebuilt) by MMPs. Furthermore, and besides the classical role of MMPs in degrading ECM, MMPs also modulate the tumor microenvironment through the release of growth factors, cryptic sites or angiogenic factors or through the generation of matrix fragments that inhibit tumor cell proliferation, migration and angiogenesis (141) . As an example, Stromolysin-3 (ST-3) proved to be particularly abundant in the stroma adjacent to the invasive basaloid tumor islands (142, 143) . Interestingly, ST-3 is expressed in fibroblasts also during cutaneous scar formation, i.e. further supporting the close link between normal wound-healing response and carcinogenesis (144) . Along with MMPs, also their inhibitors, the tissue inhibitor of metalloproteinases (TIMPs), are expressed and especially TIMP-1 expression was found to be upregulated in the stroma of BCCs (145) , thereby pointing to effective mechanisms to control degradation in the tumor microenvironment.
SCC microenvironment and tumor heterogeneity
Because of the slow and step-wise development of cutaneous SCCs, it is not surprising that these tumors are characterized by remarkable heterogeneity also accompanied by regional differences in tumorstroma interaction. Accordingly, heterogeneity in cellular regulation within the same tumor is well documented, e.g. for cyclin D1 and telomerase/hTERT overexpression or an aberrant Wnt pathway activation evident by staining for nuclear b-catenin ((146-148) and references therein; Wischermann et al., submitted for publication). Variations in tumor-stroma interactions can also be recognized as regional variability of aberrant Wnt signaling (148) , own observations. In addition, Wnt activation is found in stromal fibroblasts at discrete sites. As we can show that Wnt-stimulated fibroblasts express growth factors and MMPs that support epidermal growth and invasion (Wischermann et al., submitted for publication) this is consistent with the concept that molecular and functional variations as a result of aberrant Wnt signaling are not restricted to the tumor cells (tumor heterogeneity) but also extend to the stroma.
In analogy, aberrant Wnt signaling is one of the driving forces of colon cancer formation (reviewed in ref. 149) . A similar heterogeneous pattern of nuclear b-catenin was found (reviewed in ref. 150) , with high activity of the Wnt pathway preferentially in tumor cells located close to stromal myofibroblasts. This indicates that Wnt activity and cancer stemness were regulated by extrinsic cues, i.e. myofibroblastderived factors. Importantly, these factors also elicited reprogramming of non-tumorigenic cancer cells toward de-differentiation, expression of CSC markers and regaining of tumorigenic capacity (151) . On the same lines, Malanchi et al. showed that in mouse cutaneous SCCs, the maintenance of CSCs required b-catenin signaling. Ablation of the b-catenin gene resulted in loss of CSCs and complete tumor regression (146) . However, it remained unclear which upstream events caused aberrant Wnt signaling. Thus, also in human skin, SCCs myofibroblasts may participate in this niche-dependent function.
Another essential stromal component is the vascular supply. In brain tumors, CSCs have been shown to home in close proximity to endothelial vascular tubes in a perivascular niche. It is well established that brain tumors and their CSCs actively promote recruitment and formation of new blood vessels by secreting the pro-angiogenic factors vascular endothelial growth factor (VEGF) and stromal cellderived factor 1 (152), thereby maintaining a vascular supply and their own specific microenvironment. Recently, a vascular niche involving a VEGF-Neuropilin-1 loop was also identified in skin tumors (153) . In mouse, papillomas induced by the two-stage skin carcinogenesis protocol CSCs localized in a perivascular niche, in immediate vicinity of endothelial cells. Blockade of the VEGF-receptor in endothelial cells of these mice caused tumor regression not only by decreasing the microvascular density but also by reducing the CSC pool size. Moreover, deletion of the VEGF co-receptor Nrp1, which is essential for VEGF-receptor function in these cutaneous CSCs, blocked VEGF's ability to promote cancer stemness and renewal (153) .
The functional importance of a vascular niche is further confirmed by studies with human skin carcinoma cells. Invasive growth of skin SCC cells after transplantation onto mice correlated with sustained angiogenesis (154) . Moreover, tumorigenicity could be provoked by expression of the pro-angiogenic factor PDGF-B even in nontumorigenic HaCaT keratinocytes injected subcutaneously into immunodeficient mice what resulted in a marked mesenchymal cell proliferation and angiogenic response (155) . In this transplantation model, endothelial cells are rapidly attracted when the tumor cells are transplanted on a collagen-based matrix (156) . However, when enclosing a hyaluronic acid meshwork that induced a stromal reaction including ECM condensation, blood vessel growth toward the tumor cells was hindered and the highly invasive tumor cells reverted to a non-invasive highly differentiated phenotype (157) . This demonstrates that changes in the ECM clearly influenced the interaction with the perivascular niche and together with their decreased proliferation the tumor cells lost their invasive potential. Importantly, this inhibitory effect applied to well-differentiated low-grade tumor cells as well as to highly aggressive (metastatic) skin cancer cells further supporting the role of the microenvironment as a potent effector of tumor growth (146) .
In agreement with the angiogenic niche, thrombospondin 1 (TSP1), a matrix glycoprotein known for its anti-angiogenic properties could be defined as a specific ECM component (for review, see ref. 158 ). TSP1 is a constituent of the microenvironment of human keratoacanthomas, benign SCC precursor lesions, but largely absent in that of SCCs (159) . Accordingly, overexpression of TSP1 in human SCC cells not only prevented tumor cell invasion by depositing TSP1 along the tumor-stroma border and halting tumor vascularization but reverted the tumor phenotype to a benign epidermal cyst with low proliferative capacity when investigated as xenotansplants (160) . After several weeks, when TSP1 became degraded a fully vascularized invasive carcinoma was restored (P.Boukamp, unpublished results). Whether these changes in vasculogenesis and phenotype shift have similar consequences for the pool size of CSCs and their renewal properties in human SCCs as proposed by Blanpain et al. for the vascular niche model of mouse papillomas (153) awaits further investigation.
Epidermal stem cell niche
Modulation of the environment by MMPs As in BCCs, the microenvironment in SCCs is not static but intensely remodeled by the action of MMPs. A number of MMPs were identified by their RNA expression in the tumor but also in the stroma (reviewed in ref. 141 ). In particular, MMP-9, supplied by inflammatory cells, was shown to contribute massively to mouse skin carcinogenesis (161) . As cell-matrix interactions are important for the regulation of MMPs, changes in the compositions of different BM components may influence MMP expression (141) . In support of this, expression of the BM components type VII and IV collagens was reduced in human SCC as compared with BCC, whereas MMP-2 and MMP-9 were upregulated and the authors suggested that this could account for the increased invasive potential of SCC versus BCC (162) . In addition, significantly higher levels of tissue inhibitor of metalloprotease TIMP-2 were detected in less infiltrative BCC when compared with SCCs or infiltrative BCCs. However, also SCCs expressed TIMPs in stromal cells in the vicinity of the tumor thus being able to counteract and to fine-tune MMP activity, supposedly as a host response to limit invasion and angiogenesis (163) and for review, see ref. (164) . Taken together, tumor activation and progression are inevitably associated with matrix turnover and remodeling. Proteolytic enzymes, in particular MMPs, are at the heart of this process. Therefore, it is reasonable to conclude that also they participate in the control of maintenance and functionality of stem cell niches.
Contribution of the immune system
Finally, an important microenvironmental aspect of cutaneous SCCs is the impact of the immune system. In contrast to the long latency of human skin SCC (30-40 years), immunosuppressed transplant recipients are highly prone to develop SCCs within the following 5-10 years (165) . In these patients, the common incidence ratio of BCCs to SCCs reverts from 4:1 to 1:3, also termed 'catastrophic cutaneous carcinomatosis' (166) . This clearly demonstrates the paramount importance of the immune system in controlling SCCs, probably not by radically eliminating the tumor cells but by keeping them in a 'dormant' stage. Interestingly, a recent survey on heart transplant recipients indicated several factors such as the age at transplantation (.45 years), therapy conditions and high sunshine exposure as risk factors for the development of non-melanoma skin cancer, preferentially SCCs (165) . Especially the different immune suppressive compounds and the higher dosage given to both heart and kidney transplant recipients increased the risk of developing SCCs but not BCCs (165, 167) . As side effects of immunosuppressive compounds, oncogenic potential through induced production of cytokines that promote tumor growth, metastasis and angiogenesis has been presumed. Thus, understanding the mechanisms of how immune suppressive compounds accelerate SCC progression will clearly help to unravel the stromal properties required for SCC development; hence, better and less harmful immunosuppressive strategies may be applied. In addition, more profound insight into niche-dependent stem cell regulation is urgently needed in order to recognize new opportunities for prevention of or therapeutical intervention in tumor formation in these immunosuppressed patients.
Conclusions and perspectives
Skin belongs to the organs that have been subjects of stem cell research for a long time. Extensive knowledge has been accumulated about the characteristics and diversity of stem cells in murine HF. However, a comparable gain of insight is still awaited concerning human stem cells in HF and particularly in the IFE. Since IFE predominates the human body surface, it may even be considered as the superior stem cell site in human skin. It also became clear throughout the years that the stem cell's microenvironment, the niche, is just as important for stem cell maintenance and functionality as the stem cell's intrinsic potential. Consequently, evidence has emerged about the interplay between epidermis and their microenvironment, the stromal fibroblasts and their matrix. As a consequence of the constant renewal of the epidermis, the stem cells are the only cells remaining in the epidermis for extensive periods and, thus, can accumulate damage to such an extent that tumor initiation and progression is elicited. Based on that, the epidermal somatic stem cells are most likely the skin carcinoma-initiating cells. Even though the terminological confusion is not solved, yet, the concept of CSCs seems to apply to human cutaneous SCCs as well. Furthermore, the decisive role of the stem cell niche also in carcinogenesis is now well acknowledged.
Experimental prerequisites to study stem cell biology in human normal skin and cutaneous carcinomas have been developed over the last few years. Seminal investigations concerning the distribution of normal human IFE stem cells have been undertaken by Ghazizadeh and Taichman (16) who transplanted human skin onto the back of immunosuppressed mice. In order to avoid heterogeneity between different skin samples, as a next step OTCs made of precultivated human keratinocytes and dermal fibroblasts were transplanted onto immuno-incompetent mice. Beyond the profound studies on regulation of normal cells, these humanized mouse models have permitted to also model several monogenic skin diseases, when keratinocytes and fibroblasts with genetic defects were used (168, 169) . Similarly, humanized mouse models have been used to study the tumor-stroma interaction at early stages of tumor cell invasion (155, 170, 171) . Along the same line, it was recently demonstrated that preimplantation of a humanized stromal equivalent and thereby creating a fibrovascular bed significantly improved the take rate and allowed successful xenotransplantation of tumor cells from primary human cutaneous SCCs (126, 172) . Alternatively, keratinocytes were inoculated into devitalized rat tracheas and transplanted subcutaneously into SCID mice in order to achieve their long-term survival (173) . Exploiting this model, Kaur et al. elegantly provided functional evidence that quiescent keratinocyte stem cells and their progeny are hierarchically organized in human skin epidermis (174) .
Last not least, OTCs serve as in vitro skin models thereby representing a valid alternative to in vivo studies (43, 49, (175) (176) (177) (178) (179) (180) (Figure 2A) . Restrictions due to their generally short culture life have been overcome by modifying the dermal equivalent (17, 176, 180) . These longterm OTCs build up a largely normal epidermis ( Figure 2B-D) with all structural features essential for epidermal integrity ( Figure 2B-E) , whereas incorporated dermal fibroblasts secrete abundant matrix, generating a dermal equivalent with authentic ECM (49); Figure 2F . This environment provides an appropriate niche allowing stem cells to establish as LRCs in the basal layer of the epidermis (Figure 2G-M) . Although mostly quiescent, and therefore maintaining their label, they contribute to epidermal tissue regeneration by an as yet unidentified proliferative stimulus ( Figure 2J-K) (19) . Thus, the major achievement of these advanced in vitro skin equivalents is their potential to recapitulate a largely physiological microenvironment that is permissive for the establishment of a stem cell niche with long-term stem cell regeneration and tissue-specific differentiation, thereby facilitating access to in depth characterization of the underlying mechanisms also with human cells.
Extending the OTC model also to tumor cells, further expands its applicability. This approach now allows for controlled studies of signaling events underlying cancer biology and for the analysis of the microenvironment as a crucial regulator of tumor tissue specificity (181-184) (and for review, see refs 185,186) . Human organotypic epithelial tumor models are already used to study key features of tumor progression, including rapid invasion through an intact BM (187) or the more protracted process of stromal conditioning for the onset and persistence of tumor cell invasion (J.Kollar et al., in preparation; B.Falkowska-Hansen, P.Boukamp, unpublished results). Furthermore, systems biology modeling is a powerful tool to integrate these findings systematically into cellular signaling networks. Actually, an extracellular matrix interaction network involved in cancer progression has recently been identified by applying an OTC-based tumor model (171) . Altogether, human models are now available, providing a broad range of versatility by incorporating genetically engineered human cells and deliberately adjusting the culture conditions, including stimulatory and inhibitory factors as well as K. Boehnke et al. modulating the matrix composition. This advanced platform technology has the exciting potential to progressively reveal the dynamic interaction of human skin and tumor stem cells with their microenvironment. Consequently, the gain in understanding 'stem cells in their niche' is likely to provoke novel therapeutics in both regenerative medicine and cancer treatment.
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